Sort
17,288 grants matching “multiple sclerosis”
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
$258,308Brendan D. Manning · Harvard School Of Public Health · R01 · FY2011 · CA
Endogenous Retroviruses and Gene Regulation After Injury
$258,300Kiho Cho · University Of California At Davis · R01 · FY2009 · GM
Endogenous Retroviruses and Gene Regulation After Injury
$258,300Kiho Cho · University Of California At Davis · R01 · FY2010 · GM
Molecular Biology of Coronavirus Induced Demyelination
$258,290Susan R. Weiss · University Of Pennsylvania · R01 · FY2007 · AI
BIOCHEMISTRY OF MACROPHAGE NITRIC OXIDE SYNTHESIS
$258,192Cleveland Clinic Foundation · R01 · FY2000 · CA
Small molecule target for suppression of autoimmunity in rheumatoid arthritis
$258,166Scott McNear Thacher · Orphagen Pharmaceuticals · R43 · FY2007 · AR
SUPPRESSION OF CNS AUTOIMMUNE DISEASE BY TH2 CELLS
$258,157University Of Southern California · R01 · FY2000 · NS
ACTIVATION OF NF-KB IN GLIAL CELLS AND CNS OF EAE
$258,125University Of Nebraska Medical Center · R01 · FY2001 · NS
ORAL TOLERANCE IN PLP INDUCED EAE--MOLECULAR MECHANISMS
$258,069Northwestern University · R01 · FY2002 · AI
K-Channels in Lymphocyte Function and Autoimmunity
$258,062George Kanianthara Chandy · University Of California-Irvine · R01 · FY2006 · NS
Modulation of myelination by IL-4 following intrauterine growth restriction
$258,000Judith B Grinspan · Children'S Hosp Of Philadelphia · R21 · FY2018 · NS
MRS OF NEUROPROTECTION IN AN SIV MODEL OF NEUROAIDS
$257,913Eva-Maria Ratai · Massachusetts General Hospital · R21 · FY2007 · NS
Mayo Rehabilitation Research Training Center
$257,906Mayo Clinic · T32 · FY2005 · HD
Experimental Therapeutics in Neurological Disease
$257,790Robert C Griggs · University Of Rochester · T32 · FY2007 · NS
A telehealth tDCS approach to decrease cannabis use: Towards reducing multiple sclerosis disability in multiple sclerosis
$257,761Leigh Charvet · New York University School Of Medicine · R21 · FY2022 · DA
ACTIVATION OF NF-KB IN GLIAL CELLS AND CNS OF EAE
$257,760University Of Nebraska Medical Center · R01 · FY2002 · NS
HUMAN CARTILAGE GP39 IN HLA-DR4 TRANSGENIC MURINE MODEL
$257,732Case Western Reserve University · R01 · FY2003 · AR
Impact of Acute Cannabis Administration on Pain Symptomology and Inflammatory Markers among Patients with Rheumatoid Arthritis
$257,681Elizabeth Aston · Brown University · P20 · FY2019 · GM
Protection from Mucosal Pathology by Gut Microbiota during Colitis
$257,645Sarkis K Mazmanian · California Institute Of Technology · R01 · FY2014 · DK
The Role of microRNAs in autoimmune disease
$257,495Lukas T. Jeker · University Hospital Basel · R01 · FY2017 · AI
Training in Immunological Mechanisms
$257,278Michael Croft · La Jolla Institute For Immunology · T32 · FY2023 · AI
Chemokines and Chemokine Receptors in Multiple Sclerosis
$257,273Richard M Ransohoff · Cleveland Clinic Lerner Com-Cwru · P01 · FY2007 · NS
Treatment strategies for autoimmune demyelinating optic neuritis
$257,250Scott M Plafker · Oklahoma Medical Research Foundation · R21 · FY2016 · EY
IMMUNOPATHOGENESIS OF VIRUS-INDUCED DEMYELINATION
$257,250University Of Iowa · R01 · FY2003 · NS
Microstructural Characterization of the Optic Nerve in Optic Neuritis
$257,250Seth A Smith · Vanderbilt University · R01 · FY2015 · EY